Sign In
Buy ZYME
$22.86
-0.260 (-1.12%)
At Close: Jul 24, 2026
7 Small-Cap Stocks With Significant Upside Potential in 2024
10:04am, Thursday, 15'th Feb 2024
Investing in small-cap stocks offers multiple advantages for those looking to diversify their portfolios with potential high-growth opportunities efficiently. Small-cap stocks strike a unique balance
Zymeworks To Host Fourth Quarter and Full Year 2023 Results Conference Call
06:00am, Wednesday, 14'th Feb 2024
VANCOUVER, British Columbia, Feb. 14, 2024 (GLOBE NEWSWIRE) -- Zymeworks Inc. (Nasdaq: ZYME), a clinical-stage biotechnology company developing a diverse pipeline of novel, multifunctional biotherapeu
3 Top Stocks to Buy This Winter for Sizzling Summer Gains
06:14pm, Wednesday, 31'st Jan 2024
The Bulls are back in charge on Wall Street. Major stock indices like the S&P 500 and Dow have powered to new highs recently, with the tech-heavy Nasdaq poised to follow.
Zymeworks Announces Participation in Upcoming Investor Conferences
06:00am, Wednesday, 31'st Jan 2024
VANCOUVER, British Columbia, Jan. 31, 2024 (GLOBE NEWSWIRE) -- Zymeworks Inc. (Nasdaq: ZYME), a clinical-stage biotechnology company developing a diverse pipeline of novel, multifunctional biotherapeu
Zymeworks Inc. (ZYME) Is Up 1.64% in One Week: What You Should Know
01:32pm, Thursday, 11'th Jan 2024
Does Zymeworks Inc. (ZYME) have what it takes to be a top stock pick for momentum investors? Let's find out.
$10K to $100K: Small-Cap Marvels With Massive Upside
02:11am, Monday, 08'th Jan 2024
Unlocking the potential of small-cap stocks often reveals sky-bound potential. The three listed stocks in the article offer substantial growth opportunities.
Small-Cap Sensations: 3 Stocks Predicted for Massive Growth in 2024
06:20am, Tuesday, 26'th Dec 2023
As investors, small-cap stocks offer us the possibility of monumental returns. If you play your cards right, small-caps can deliver gains most blue chips could never match.
From $10k to $100k in 5 years: 3 Small-Cap Stocks to Make a Fortune
02:53pm, Monday, 25'th Dec 2023
In the pulsating realm of small-cap stocks, a select few emerge as trailblazers, poised to revolutionize industries and redefine investment landscapes. Enter the triumphant trio of three under-the-rad
Biotech breakthroughs: Stocks that soared from medical innovations
09:08am, Wednesday, 20'th Dec 2023
On the heels of the devastating COVID-19 pandemic, investor enthusiasm for biotech stocks waned as the Federal Reserve embarked on its aggressive rate-hiking campaign to bring down the red-hot inflati
Want to Turn Spare Change Into $1,000? Buy These 3 Stocks Now
06:15pm, Monday, 18'th Dec 2023
We've all had the experience of emptying our pockets at day's end to find a collection of coins. Sure, you could cash them in at a Coinstar machine for some bills.
Next Wave Biotech: 3 Stocks Poised for Breakthrough Success
12:04pm, Wednesday, 13'th Dec 2023
The pandemic pushed major biotech stocks into the spotlight as vaccine demands rose to unprecedented highs. Investors flocked to the industry in the next few years after the COVID-19 breakout.
The 7 Best Bargain Growth Stocks to Buy Before 2024
04:17pm, Monday, 11'th Dec 2023
When you hear the term “growth stocks,” you probably think of high-growth yet unprofitable companies diluting shareholders through secondary offerings just to fund more losses. But that doesn't al
Does Zymeworks Inc. (ZYME) Have the Potential to Rally 42.84% as Wall Street Analysts Expect?
11:18am, Friday, 01'st Dec 2023
The average of price targets set by Wall Street analysts indicates a potential upside of 42.8% in Zymeworks Inc. (ZYME). While the effectiveness of this highly sought-after metric is questionable, the
Zymeworks Announces Participation in Upcoming Investor Conference
08:30am, Thursday, 30'th Nov 2023
VANCOUVER, British Columbia, Nov. 30, 2023 (GLOBE NEWSWIRE) -- Zymeworks Inc. (Nasdaq: ZYME), a clinical-stage biotechnology company developing novel, multifunctional biotherapeutics, today announced
3 Beaten-Down Stocks to Buy for 1,000% Upside in Five Years
07:00am, Thursday, 30'th Nov 2023
After over a decade of smooth sailing, stocks have been exceptionally turbulent for the past three years. Rising rates, high inflation, recession fears – you name it, and the bears have used it to m
